3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Hepatoblastoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
GATA2 Deficiency
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Anemia, Refractory
1
Interventions
Vincristine
7
Cyclophosphamide
7
Methotrexate
6
Dexamethasone
6
Cytarabine
6
merphos
5
Mercaptopurine
5
Doxorubicin
5
pegaspargase
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
blinatumomab
4
azathiopurine
4
auricularum
4
Prednisone
4
Leucovorin
4
Inotuzumab Ozogamicin
4
Calcium Dobesilate
4
prednylidene
3
deltacortene
3
Thioguanine
3
Specimen Handling
3
N,N-dicyclohexyl-isoborneol-10-sulfonamide
3
Methylprednisolone
3
Asparaginase
3
calaspargase pegol
2
asparaginase erwinia chrysanthemi recombinant
2
Spinal Puncture
2
Rituximab
2
Radiotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
×
Vorinostat
×
90 days
×
Clear all
No trials found.